You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser.
Administrator
Staff member
-
cafead   Apr 03, 2019 at 10:12: AM
Administrator
Staff member
via Clinical-stage biopharmaceutical firm Xencor has entered into a research collaboration with Astellas Pharma for novel bispecific antibody program.
article source
<